London-based Big Picture Bio emerges from stealth with €2.55 million to develop AI-designed cancer drug combinations
Big Picture Bio, a London-based BioTech startup developing AI-designed combination therapies for cancer and other complex diseases, has emerged from stealth with a combined funding round of €2.55 million (£2.2 million). The funding comprises a €1.75 million (£1.5 million) pre-Seed round co-led by Ka
<p>Big Picture Bio, a London-based BioTech startup developing AI-designed combination therapies for cancer and other complex diseases, has emerged from stealth with a combined funding round of €2.55 million (£2.2 million). The funding comprises a €1.75 million (£1.5 million) pre-Seed round co-led by Ka</p>